Abbott Laboratories (ABT) Stock Forecast
ABT analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.54 / 5 from 28 analysts
- Price target
- $120.72 average of analyst targets
- Upside to target
- +15.1% from the latest close
- Next earnings
- October 21, 2026 EPS estimate $1.42
- 52-week range
- $82.56 – $130.59
ABT analyst ratings
28 analystsNumber of analysts at each rating.
ABT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ABT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.41 | $1.31 | $1.44 | $1.30 | +8.8% | 23 |
| Current fiscal year (2026) | $5.52 | $5.45 | $5.56 | $5.15 | +7.1% | 27 |
| Next fiscal year (2027) | $6.07 | $5.88 | $6.20 | $5.52 | +9.9% | 27 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ABT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $12.99B | $12.93B | $13.14B | +14.3% | 24 |
| Current fiscal year (2026) | $50.20B | $47.61B | $50.71B | +13.2% | 27 |
| Next fiscal year (2027) | $54.53B | $51.42B | $55.40B | +8.6% | 27 |
ABT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ABT revenue: reported and forecast
ABT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.42 | $1.42 | $1.42 | $1.42 | $1.41 | −0.2% | 1 up · 1 down |
| Current fiscal year (2026) | $5.51 | $5.52 | $5.52 | $5.52 | $5.52 | +0.2% | 1 up · 2 down |
| Next fiscal year (2027) | $6.07 | $6.06 | $6.07 | $6.07 | $6.07 | −0.0% | 1 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ABT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ABT beat in 12 of 12.
What analysts expect from ABT
28 analysts cover Abbott; their consensus rating is strong buy (4.54 on a 1–5 scale, where 5 is a strong buy). The average price target is $120.72, 15.1% above the latest close of $104.89. Analysts expect earnings of $5.52 per share for 2026, +7.1% from a year earlier. For 2027 the average estimate is $6.07 per share on revenue of $54.5 billion. Abbott beat the EPS estimate in 12 of the last 12 quarters.
Related: ABT income statement, ABT key metrics, ABT chart. See the ABT stock overview for the latest quote and news.
ABT forecast FAQ
What is Abbott's price target?
The average analyst price target for Abbott is $120.72, 15.1% above the latest close of $104.89.
Is Abbott a buy, hold or sell?
Of 28 analysts covering Abbott, 19 rate it a strong buy, 5 a buy, 4 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Abbott's EPS forecast?
Analysts forecast $5.52 per share for 2026 (range $5.45 to $5.56); for 2027 the estimate is $6.07.
What is Abbott's revenue forecast?
The average revenue estimate for 2026 is $50.2 billion, growth of 13.2%; for 2027 it is $54.5 billion.
When does Abbott report earnings?
Abbott is expected to report results for the quarter ending September 30, 2026 on October 21, 2026 before the market opens; the EPS estimate is $1.42.
Does Abbott usually beat earnings estimates?
Abbott reported EPS at or above the analyst estimate in 12 of the last 12 quarters.